Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vasodilators for heart failure--useful or useless?

J A Franciosa1

  • 1Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia.

Cardiology
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rationale, design, and methods for a Coreg (carvedilol) Heart Failure Registry (COHERE). COHERE Participant Physicians.

Journal of cardiac failure·2000
Same author

Beta-adrenergic blocking agents: past, present, and future perspectives.

Coronary artery disease·1999
Same author

Commentary on the use of run-in periods in clinical trials.

The American journal of cardiology·1999
Same author

Acute hemodynamic effects of norepinephrine inhibition in patients with severe chronic congestive heart failure.

Journal of the American College of Cardiology·1989
Same author

Beta-receptor-active agents: role of partial agonists in patients with heart failure.

Journal of cardiovascular pharmacology·1989
Same author

Application of noninvasive techniques for measuring cardiac output in hypertensive patients.

American heart journal·1988
Same journal

Reply Letter.

Cardiology·2026
Same journal

Aortic Valve Sclerosis: More Than an Incidental Echocardiographic Finding.

Cardiology·2026
Same journal

Can resting segmental strain identify obstructive coronary artery disease in chronic coronary syndrome patients referred to CABG?

Cardiology·2026
Same journal

Mortality Impact of Stroke and Major Bleeding Across the Ejection Fraction Spectrum in Patients Hospitalized for Acute Heart Failure With Prevalent Atrial Fibrillation.

Cardiology·2026
Same journal

Impact of Inflammatory Disorders on Outcomes in Acute Heart Failure: A Nationwide Analysis.

Cardiology·2026
Same journal

Predictors and Clinical Impact of Tricuspid Regurgitation After Pericardiectomy for Constrictive Pericarditis.

Cardiology·2026
See all related articles

Vasodilators improve heart failure symptoms and survival, particularly venodilators like nitrates and ACE inhibitors when combined with digitalis and diuretics. Their use alone or for preventing heart failure needs more research.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Vasodilators are increasingly used for congestive heart failure management.
  • They offer hemodynamic and clinical benefits in acute and chronic heart failure.

Purpose of the Study:

  • To evaluate the efficacy of vasodilators in managing congestive heart failure.
  • To assess the role of vasodilators without digitalis or diuretics.
  • To explore the potential of vasodilators in preventing heart failure progression.

Main Methods:

  • Review of existing literature on vasodilator efficacy.
  • Analysis of hemodynamic and clinical outcomes in heart failure patients.
  • Evaluation of specific vasodilator classes, including nitrates and ACE inhibitors.

Main Results:

Related Experiment Videos

  • Vasodilators, especially venodilators (nitrates, ACE inhibitors), improve symptoms, function, and survival in moderate to severe heart failure when added to digitalis and diuretics.
  • Prompt hemodynamic and clinical improvement observed in acute left ventricular failure.

Conclusions:

  • Venodilating vasodilators are effective adjuncts in moderate to severe heart failure management.
  • Further research is needed to determine the utility of vasodilators used alone and their role in preventing heart failure development or progression.